Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Agomelatine

02 6Indapamida; Perindopril Erbumina

03 2Indapamide; Perindopril Terc-Butylamine

04 2Ivabradinhydroklorid

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : Agomelatine Anpharm

FNCE
Not Confirmed
arrow

Brand Name : Agomelatine Anpharm

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Film Coated Tablet

Brand Name : Agomelatine Anpharm

Dosage Strength : 25mg

Packaging :

Approval Date : 28/09/2018

Application Number : 20170703000110

Regulatory Info : Deregistered

Registration Country : Sweden

blank

02

Brand Name : Bipreterax

FNCE
Not Confirmed
arrow

Brand Name : Bipreterax

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Tablet

Brand Name : Bipreterax

Dosage Strength : 4MG; 1.25 MG

Packaging :

Approval Date : 2021-12-15

Application Number : OGYI-T-6831-01IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

03

Brand Name : Bipreterax

FNCE
Not Confirmed
arrow

Brand Name : Bipreterax

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Tablet

Brand Name : Bipreterax

Dosage Strength : 8MG; 2.5 MG

Packaging :

Approval Date : 2023-10-27

Application Number : OGYI-T-6831-02IP2

Regulatory Info : Authorized

Registration Country : Spain

blank

04

Brand Name : Bipreterax

FNCE
Not Confirmed
arrow

Brand Name : Bipreterax

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Tablet

Brand Name : Bipreterax

Dosage Strength : 8MG; 2.5 MG

Packaging :

Approval Date : 2020-04-16

Application Number : OGYI-T-6831-02

Regulatory Info : Authorized

Registration Country : Spain

blank

05

Brand Name : Bipreterax

FNCE
Not Confirmed
arrow

Brand Name : Bipreterax

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Tablet

Brand Name : Bipreterax

Dosage Strength : 8MG; 2.5 MG

Packaging :

Approval Date : 2022-10-24

Application Number : OGYI-T-6831-02IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

06

Brand Name : Bipreterax

FNCE
Not Confirmed
arrow

Brand Name : Bipreterax

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Tablet

Brand Name : Bipreterax

Dosage Strength : 4MG; 1.25 MG

Packaging :

Approval Date : 2020-04-03

Application Number : OGYI-T-6831-01

Regulatory Info : Authorized

Registration Country : Spain

blank

07

Brand Name : Bipreterax

FNCE
Not Confirmed
arrow

Brand Name : Bipreterax

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Tablet

Brand Name : Bipreterax

Dosage Strength : 8MG; 2.5 MG

Packaging :

Approval Date : 2021-12-15

Application Number : OGYI-T-6831-02IP

Regulatory Info : Authorized

Registration Country : Spain

blank

08

Brand Name : Bipreterax

FNCE
Not Confirmed
arrow

Brand Name : Bipreterax

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Tablet

Brand Name : Bipreterax

Dosage Strength : 4MG; 1.25 MG

Packaging :

Approval Date : 2023-10-10

Application Number : OGYI-T-6831-01IP2

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Brand Name : Bipreterax

FNCE
Not Confirmed
arrow

Brand Name : Bipreterax

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Tablet

Brand Name : Bipreterax

Dosage Strength : 4MG; 1.25 MG

Packaging :

Approval Date : 2024-07-26

Application Number : OGYI-T-6831-01IP3

Regulatory Info : Authorized

Registration Country : Spain

blank

10

Brand Name : Ivabradine Anpharm

FNCE
Not Confirmed
arrow

Brand Name : Ivabradine Anpharm

arrow
FNCE
Not Confirmed

Anpharm

Dosage Form : Film Coated Tablet

Brand Name : Ivabradine Anpharm

Dosage Strength : 5mg

Packaging :

Approval Date : 08/09/2015

Application Number : 20150524000018

Regulatory Info : Approved

Registration Country : Sweden

blank